Miriam Atkins Md Considers What Coa Is Doing To Educate Patients On Their Cancer Care Obroncology Mp3 & Mp4 Download

0:24

miriam atkins, md, elaborates on what cancer patients can do to advocate for themselves

0:32

miriam yvette jones atkins, md, on how the coa patient advocacy network benefits patients

0:15

miriam yvette jones atkins, md, on involving patients in the coa patient advocacy network

0:32

miriam yvette jones atkins, md, explains how the coa patient advocacy network makes a difference

1:03:38

dr. miriam atkins, medical oncologist

0:55

michael atkins, md, on mrcc patients whose cancer returns and were previously treated with i-o

1:33

michael soulen, md, compares the possible benefits of retrospective vs. prospective trials

0:45

coa is helping community oncologists by fighting the cms asp experiment by jeff patton, md

3:50

caitlin costello, md and the insight-mm study

0:39

mohamad e. allaf, md, on helping non-metastatic renal cell carcinoma patients with adjuvant therapy

0:19

understanding inflammatory arthritis in cancer patients caused by checkpoint inhibitors (:18)

1:09

catherine diefenbach, md, regarding the unmet needs in the management of follicular lymphoma

1:20

mohamad e. allaf, md, on non-metastatic renal cell cancer patients and adjuvant therapy

1:42

nutritional support for breast cancer

1:13

miriam atkins, md, considers what coa is doing to educate patients on their cancer care

Download video MP4

Download video MP3

Similar videos

miriam atkins, md, elaborates on what cancer patients can do to advocate for themselves

miriam yvette jones atkins, md, on how the coa patient advocacy network benefits patients

miriam yvette jones atkins, md, on involving patients in the coa patient advocacy network

miriam yvette jones atkins, md, explains how the coa patient advocacy network makes a difference

dr. miriam atkins, medical oncologist

michael atkins, md, on mrcc patients whose cancer returns and were previously treated with i-o

michael soulen, md, compares the possible benefits of retrospective vs. prospective trials

coa is helping community oncologists by fighting the cms asp experiment by jeff patton, md

caitlin costello, md and the insight-mm study

mohamad e. allaf, md, on helping non-metastatic renal cell carcinoma patients with adjuvant therapy

understanding inflammatory arthritis in cancer patients caused by checkpoint inhibitors (:18)

why are patients with kidney disease often not considered for clinical trials?

stillwell-why i chose to be an oncologist

meet our doc: anna franklin, md, center for cancer and blood disorders

agne paner, md | mcrt chicago, illinois april 30, 2022

catherine diefenbach, md, regarding the unmet needs in the management of follicular lymphoma

mohamad e. allaf, md, on non-metastatic renal cell cancer patients and adjuvant therapy

nutritional support for breast cancer

mark witte, describes the development process of a new cancer care model to design a new center